@ofidjournal.bsky.social Take a read of our recent study assessing use of mcfDNA-NGS relative to standard testing in the workup of FUO. Molecular testing offered earlier time to diagnosis and some interesting non-hypothesis driven diagnoses. academic.oup.com/ofid/article...

Concordance of non-invasive plasma cell-free DNA with invasive diagnostics for diagnosis of invasive fungal disease ✅ Just Accepted

Wow,timely! Spinal implant infections are a serious complications of instrumented spinal fusion surgeries,carrying high morbidity & complex management challenges 🆕️🔥State-of-the-Art Review: Diagnosis and Management of Spinal Implant Infections #idsky #EMIMCC #medsky academic.oup.com/cid/article/...

🆕️✨️The largest study to date of patients with Bacteroides spp. bacteremia in ISAC Journal, IJAA. #IDsky

🆕🔥Clinical Insights #JAMAInternalMed When Can a MRSA Nares Swab Guide Antibiotic Stewardship? What the Nose Knows #idsky #medsky #AMSsky #EMIMCC jamanetwork.com/journals/jam...

I love it🔥 ASymptomatic Bacteriuria #idsky #medsky #utisky #AMSsky

New in @cidjournal.bsky.social State-of-the-Art Review: Ocular Infections Miriam Barshak and multidisciplinary team #IDSky #OphthoSky #MedSky @nottheogdrv.bsky.social academic.oup.com/cid/article/...

If you have access listen to #IDweek presentation in the Era of shorted is better. @maricarmalinis.bsky.social #TxID #IDSky

#ShorterIsBetter in immunocompromised hosts? Short treatments are feasible in early responders without source control issues. A significant number of observational studies serve as proof-of-concept on the feasibility of short courses in selected patients (see ⚠️) #AMSsky #IDOnc #TxID #IDsky

🌟 ABX Pearl of the Day: Duration of treatment in intra-abdominal infections (IAI)! 💊 💡 Q: How long should I treat IAI after source control? 🔍 A: While STOP-IT trial calls for 4 days post-source control, there are notable exceptions. See infographic for details 👇 #IDsky #AMSsky #MedSky #Pharmsky

Join us in Hawaii (or via livestream) on Feb. 3-7 for Infectious Diseases Practice Updates 2025! Our outstanding @MayoClinicINFD faculty will cover updates on best practices and new developments in the field. Register here: tinyurl.com/2d7tkz6x

🆕 Just published in NEJM! The BALANCE trial definitively establishes 7-day treatments as the standard of care for uncomplicated BSIs, with more than 3,600 randomized patients. Fantastic work! @drtoddlee.bsky.social www.nejm.org/doi/full/10.... #AMSsky #IDSky #ShorterIsBetter

Congratulations to @nischalr3.bsky.social and his team for their paper being selected as the @thetxidjournal.bsky.social 2024 Bob Rubin Clinical Impact Awardee - this award selects the paper felt to have the biggest impact on clinical care in #TxID! #IDSky onlinelibrary.wiley.com/doi/10.1111/...